Author:
Smetana Keaton S.,May Casey C.
Reference60 articles.
1. The global burden of disease study: implications for neurology;Menken;Arch Neurol,2000
2. Calcitonin gene-related peptide (CGRP): a new target for migraine;Russo;Annu Rev Pharmacol Toxicol,2015
3. A controlled trial of erenumab for episodic migraine;Goadsby;N Engl J Med,2017
4. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial;Tepper;Lancet Neurol,2017
5. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study;Landy;J Headache Pain,2018